WhaleCreep

Pura Vida Investments, LLC 13F holdings, Q4 2024

Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →

Pura Vida Investments, LLC disclosed 9 US equity positions worth $18.1m in its Q4 2024 13F filing. The largest position was ESTA at 28.8% of the reported book, followed by MSOS and LUNG. Against the Q3 2024 filing, it opened 0 new positions, added to 1 and reduced 7 among the top 9 holdings.

← Q3 2024 · Q1 2025 →

What did Pura Vida Investments, LLC own in Q4 2024? Top 9 positions

#StockSectorWeightValueSharesΔ sharesvs Q3 2024
1 ESTA ESTABLISHMENT LABS HLDGS INC Healthcare 28.8%$5.2m113,041 -41% reduced
2 MSOS ADVISORSHARES TR 15.8%$2.9m750,000 -54% reduced
3 LUNG PULMONX CORP Healthcare 14.5%$2.6m387,200 -24% reduced
4 QTRX QUANTERIX CORP Healthcare 13.8%$2.5m234,755 -33% reduced
5 IMDX ONCOCYTE CORP 8.6%$1.6m654,451 32% added
6 NSPR INSPIREMD INC 6.6%$1.2m450,517 0% held
7 MGX METAGENOMI INC 5.3%$954.5k264,391 -2% reduced
8 NTRA NATERA INC Healthcare 4.4%$791.5k5,000 -89% reduced
9 CUTREUR CUTERA INC 2.2%$402.7k1,141,009 -2% reduced

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.